----
Forecast & RatingOnly 1 analyst currently covers Ernexa Therapeutics (ERNA.US), with a price target of $30.00 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Aug 2, 2026; this does not constitute investment advice.
Jul 29, 2026Price forecast
$30.001321.80%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Target price forecast
Forecast dateOct 19, 2026
Forecast met0.0%
Stock price$2.11
Avg. target$22,500.0
High target$22,500
Low target$22,500
- Avg. target
- $22,500.0
- High target
- $22,500
- Low target
- $22,500
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.
